Ping An Biomedical Enters Investment Memorandum with Future Biotechnology Group
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 09 2026
0mins
Ping An Biomedical entered into a non-binding memorandum with Future Biotechnology Group. The Investment Memorandum outlines an initial investment of $30M to be paid in cash, as well as subsequent acquisitions with a consideration, in aggregate, of $60M to be settled in cash and share issuances. The Consideration Shares are to be held escrow and released in accordance with performance targets over an evaluation period of 3 years from January 2026 to December 2028.
Analyst Views on PASW
About PASW
Ping An Biomedical Co Ltd, formerly known as Majestic Ideal Holdings Ltd, is an investment holding company mainly engaged in the provision of apparel supply chain management services (SCM services). The Company operates its business through two segments. The Sales of Yarns segment is mainly engaged in the provision of yarn products, textiles and other products. The Sales of Finished Garments segment is mainly engaged in the provision of finished garments. The Company provides end-to-end supply chain solutions. The Company provides services covering functions within the supply chain of these products, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
